ArticleJournal of orthopaedic case reports2026
Influence of Menopause Onset on the Progression of Lumbar Degenerative Disease: A Clinical Correlation Study.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lumbar degenerative disease (LDD) is one of the significant causes of chronic low back pain and disability in postmenopausal women. Although age-related degeneration has been well studied, little has been done to establish how the onset of menopause and duration since menopause affect the rate of lumbar degeneration. Menopause-induced estrogen deficiency is thought to increase the rate of degenerative alteration in intervertebral disks and vertebral structures that could affect the severity of the disease and clinical outcome. Purposes: The purpose of the study was to determine the effect of age at menopause and years since menopause on the intensity of LDD and to determine the relationship between clinical manifestations and radiographical evidence in postmenopausal females. Materials and Methods: The study was a tertiary care center-based, observational cross-sectional study which lasted 12 months at this hospital. There was a total of 50 postmenopausal women aged 45 years or older who presented with persistent low back pain. The participants were divided into the early (<45 years), normal (45-50 years), and late (>50 years) menopause. Clinical evaluation involved the severity of pain based on the Visual Analog Scale and functional limitation. The lumbar spine assessment was conducted and assessed using the standard imaging on radiological assessment, and graded on the degenerative severity. Descriptive and comparative statistical data analysis was done to analyze the data. Findings: The lumbar degeneration was moderate to severe in 74% of the respondents. The highest level of severe degeneration was observed among the early menopause group (50%), normal (23.8%), and late menopause groups (20%). The highest pain scores were seen in women who were early menopausal (6.8 ± 1.4) and progressively with radiological severity. The trend of an increase in degenerative severity was noted with the length of time which passed after menopause. The clinical-radiological correlation was positive, and the higher scores on pain were associated with more advanced degenerative grades. Conclusion: Earlier menopause and longer postmenopausal years were both positively related to the severity of LDD, the level of pain, and functional impairment. The onset of menopause seems to be a significant biological factor in the development of lumbar degeneration, which is the reason why the history of menopause should be included in the clinical assessment and prevention instead of preventive measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.